Volume | 51,611,501 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.195 | Mínimo Máximo |
|||||
Minimo del Dia | 0.1356 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Kintara Therapeutics Inc | KTRA | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.195 | 0.1356 | 0.195 | 0.1488 | 0.158 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
55,997 | 51,611,501 | US$ 0.1590624 | US$ 8,209,449 | - | 0.081 - 5.98 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:59:28 | 6 | US$ 0.1425 | USD |
Información Financiera Kintara Therapeutics Inc KTRA
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
5.86M | 39.04M | - | 0 | -15.02M | -0.38 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Kintara Therapeutics Inc KTRA
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
05/4/2024 | 12:09 | PR Newswire (US) | Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to.. |
03/4/2024 | 06:00 | PR Newswire (US) | Kintara Therapeutics and TuHURA Biosciences Enter into.. |
27/3/2024 | 08:00 | PR Newswire (US) | Kintara Therapeutics Announces Expansion of REM-001 Clinical.. |
27/2/2024 | 05:59 | Edgar (US Regulatory) | Form 8-K - Current report |
26/2/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
22/2/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
14/2/2024 | 15:07 | PR Newswire (US) | Kintara Therapeutics Announces Fiscal 2024 Second Quarter.. |
12/2/2024 | 08:05 | Edgar (US Regulatory) | Form 8-K - Current report |
12/2/2024 | 08:00 | PR Newswire (US) | Kintara Therapeutics Announces Initiation of REM-001.. |
18/12/2023 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
18/12/2023 | 15:05 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
15/12/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos KTRA
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1195 | 0.195 | 0.111 | 0.1382076 | 6,883,017 | 0.023 | 19.25% |
1 Month | 0.098 | 0.24 | 0.0925 | 0.1536399 | 17,385,585 | 0.0445 | 45.41% |
3 Months | 0.1262 | 0.24 | 0.081 | 0.1254428 | 14,359,220 | 0.0163 | 12.92% |
6 Months | 3.83 | 4.48 | 0.081 | 0.1442767 | 9,853,584 | -3.69 | -96.28% |
1 Year | 2.95 | 5.98 | 0.081 | 0.1840531 | 4,976,790 | -2.81 | -95.17% |
3 Years | 78.00 | 142.50 | 0.081 | 10.44 | 2,699,553 | -77.86 | -99.82% |
5 Years | 60.50 | 167.50 | 0.081 | 14.91 | 2,320,026 | -60.36 | -99.76% |